RRC ID 66756
著者 Nagao-Kitamoto H, Leslie JL, Kitamoto S, Jin C, Thomsson KA, Gillilland MG 3rd, Kuffa P, Goto Y, Jenq RR, Ishii C, Hirayama A, Seekatz AM, Martens EC, Eaton KA, Kao JY, Fukuda S, Higgins PDR, Karlsson NG, Young VB, Kamada N.
タイトル Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.
ジャーナル Nat Med
巻・号 26(4)
ページ 608-617
公開日 2020-4-1
DOI 10.1038/s41591-020-0764-0
PII 10.1038/s41591-020-0764-0
PMID 32066975
PMC PMC7160049
MeSH Animals Bacteria / drug effects Bacteria / growth & development* Bacteria / metabolism* Clostridioides difficile / drug effects Clostridioides difficile / immunology* Clostridium Infections / immunology Clostridium Infections / prevention & control* Enterocolitis, Pseudomembranous / immunology Enterocolitis, Pseudomembranous / metabolism Enterocolitis, Pseudomembranous / microbiology Enterocolitis, Pseudomembranous / prevention & control Female Gastrointestinal Microbiome / drug effects Gastrointestinal Microbiome / physiology* Glycosylation / drug effects Host Microbial Interactions / drug effects Host Microbial Interactions / genetics Host Microbial Interactions / immunology Humans Interleukins / pharmacology Interleukins / physiology* Male Mice Mice, Inbred C57BL Mice, Knockout Veillonellaceae / drug effects Veillonellaceae / growth & development Veillonellaceae / metabolism
リソース情報
一般微生物 JCM30894 JCM16074